Loading…
Loading…
EQUITY / NASDAQ · XNCM
OSR Health, Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.1165 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 0.1165 USD · Volume 0
251 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | Prior year | Change |
|---|---|---|---|
| Revenue | 315,669 USD | — | — |
| Operating profit | -3,032,915 USD | — | — |
| Net income | -1,004,038 USD | — | — |
| Cash and cash equivalents | 1,499,603 USD | — | — |
| Total liabilities | 41,714,542 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2026 / Quarter 103/31/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 1,499,603 USD | — | — | 1,566,701 USD | 1,700,273 USD | 1,700,273 USD | 2,177,309 USD | — |
| Gross profitIncome statement | 86,605 USD | 246,886 USD | — | — | — | 592,905 USD | 261,734 USD | 463,201 USD |
| Net incomeIncome statement | -1,004,038 USD | -4,471,212 USD | -3,467,174 USD | — | — | -27,058,541 USD | -3,194,874 USD | -19,812,886 USD |
| Operating profitIncome statement | -3,032,915 USD | -6,700,098 USD | — | — | — | -18,336,003 USD | -3,803,465 USD | -11,950,469 USD |
| RevenueIncome statement | 315,669 USD | 799,727 USD | — | — | — | 2,905,805 USD | 627,747 USD | 2,524,536 USD |
| Total assetsBalance sheet | 166,623,360 USD | — | — | 172,187,773 USD | 171,238,247 USD | 171,238,248 USD | 177,289,528 USD | — |
| Total equityBalance sheet | 124,908,818 USD | — | 127,391,119 USD | 127,391,119 USD | 127,037,403 USD | 127,037,403 USD | 134,157,845 USD | — |
| Total liabilitiesBalance sheet | 41,714,542 USD | — | — | 44,796,655 USD | 44,200,845 USD | 44,200,845 USD | 43,131,683 USD | — |
| Financing cash flowCash flow statement | — | 3,415,098 USD | — | — | — | 8,368,171 USD | — | 5,156,580 USD |
| Investing cash flowCash flow statement | — | -76,648 USD | — | — | — | -2,642,991 USD | — | -69,465 USD |
| Operating cash flowCash flow statement | — | -3,422,481 USD | — | — | — | -4,328,034 USD | — | -3,258,041 USD |
| Report source | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 05/13/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 11/12/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.